Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1987 Mar;79(Suppl):23–26.

Hypertension: a view from Detroit.

R B Cubberley
PMCID: PMC2625456  PMID: 3295266

Full text

PDF
23

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bühler F. R., Burkart F., Lütold B. E., Küng M., Marbet G., Pfisterer M. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol. 1975 Oct 31;36(5):653–669. doi: 10.1016/0002-9149(75)90168-x. [DOI] [PubMed] [Google Scholar]
  2. Frishman W., Halprin S. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol. Am Heart J. 1979 Nov;98(5):660–665. doi: 10.1016/0002-8703(79)90294-1. [DOI] [PubMed] [Google Scholar]
  3. Grimm R. H., Jr, Leon A. S., Hunninghake D. B., Lenz K., Hannan P., Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med. 1981 Jan;94(1):7–11. doi: 10.7326/0003-4819-94-1-7. [DOI] [PubMed] [Google Scholar]
  4. Holland O. B., Nixon J. V., Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med. 1981 Apr;70(4):762–768. doi: 10.1016/0002-9343(81)90530-1. [DOI] [PubMed] [Google Scholar]
  5. Hollifield J. W. Biochemical consequences of diuretic therapy in hypertension. J Tenn Med Assoc. 1978 Oct;71(10):757–758. [PubMed] [Google Scholar]
  6. Hollifield J. W., Slaton P. E. Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand Suppl. 1981;647:67–73. doi: 10.1111/j.0954-6820.1981.tb02640.x. [DOI] [PubMed] [Google Scholar]
  7. Maclean D., Tudhope G. R. Modern diuretic treatment. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1419–1422. doi: 10.1136/bmj.286.6375.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mehta J., Cohn J. N. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Circulation. 1977 Feb;55(2):370–375. doi: 10.1161/01.cir.55.2.370. [DOI] [PubMed] [Google Scholar]
  9. Nies A. S., Shand D. G. Clinical pharmacology of propranolol. Circulation. 1975 Jul;52(1):6–15. doi: 10.1161/01.cir.52.1.6. [DOI] [PubMed] [Google Scholar]
  10. Opie L. H. Drugs and the heart. Lancet. 1980 Mar 29;1(8170):693–698. [PubMed] [Google Scholar]
  11. Ram C. V. Diuretics in the management of hypertension. Postgrad Med. 1982 Feb;71(2):155-9, 162-8. doi: 10.1080/00325481.1982.11715994. [DOI] [PubMed] [Google Scholar]
  12. Stern N., Teicher A., Rosenthal T. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent. Clin Cardiol. 1982 Feb;5(2):125–130. doi: 10.1002/clc.4960050202. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES